doxorubicin-teva 50 mg pulveris injekciju šķīduma pagatavošanai
teva pharma b.v., netherlands - doksorubicīna hidrohlorīds - pulveris injekciju šķīduma pagatavošanai - 50 mg
doloproct 1 mg/20 mg/g rektālais krēms
karo pharma ab, sweden - fluocortoloni pivalas, lidocaini hydrochloridum - rektālais krēms - 1 mg/20 mg/g
entonox 50%/50% medicīniskā gāze, saspiesta
linde sverige ab, sweden - dinitrogenii oxidum, skābekļa - medicīniskā gāze, saspiesta - 50%/50%
niontix 100% medicīniskā gāze, sašķidrināta
linde sverige ab, sweden - slāpekļca oksiduls - medicīniskā gāze, sašķidrināta - 100%
nurofen 200 mg ārstnieciskais plāksteris
reckitt benckiser (poland) s.a., poland - ibuprofēns - Ārstnieciskais plāksteris - 200 mg
qutavina
eurogenerics holdings b.v. - teriparatide - osteoporoze - kalcija homeostāze - qutavina is indicated in adults. osteoporozes ārstēšana sievietēm pēc menopauzes un vīriešiem ar paaugstinātu lūzuma risku. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. attieksmi pret osteoporozi saistīts ar ilgstošu sistēmisku glikokortikoīdu terapiju sievietēm, gan vīriešiem, paaugstināts lūzums.
livogiva
theramex ireland limited - teriparatide - osteoporoze - kalcija homeostāze - livogiva is indicated in adults. osteoporozes ārstēšana sievietēm pēc menopauzes un vīriešiem ar paaugstinātu lūzuma risku. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. attieksmi pret osteoporozi saistīts ar ilgstošu sistēmisku glikokortikoīdu terapiju sievietēm, gan vīriešiem, paaugstināts lūzums.
teriparatide sun
sun pharmaceutical industries europe b.v. - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalcija homeostāze - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
kauliv
strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalcija homeostāze - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.